Delivery Order SPE2DB20D3104-SPE2DB25FW0E4
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $2,303.64 to Amerisourcebergen Drug Corp, a wholly owned subsidiary of Amerisourcebergen Corporation. The contract is to provide 4564006464 - Bupropion HCL XL 300 mg tablets in 500-count containers. The delivery order contract has a performance period through March 20, 2024 and does not have a set-aside designation. This delivery order is issued under a larger indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The delivery order, valued at $12,723.06, is for the supply of 4,564,083,598 units of Bupropion HCL XL 150 mg tablets to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery order falls under a larger indefinite delivery contract (IDC) awarded...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to provide 500 units of BUPROPION HCL XL 300 MG TABLET. The contract has a total potential value of $5,376.14 and a completion date of February 5, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to provide a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,262,033 units of Bupropion HCL XL 150 mg tablets. The $10,933.71 contract has an ultimate completion date of April 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025, to deliver a wide...
- On August 14, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Bupropion HCL XL 150 mg tablets (100 unit dose packages) with a ceiling value of $2,472.49. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 15, 2025, and performance to be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- This is a delivery order under contract SPE2DB22D3301 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The delivery order is for 4,564,043,138 units of the drug Bupropion HCL XL 300 mg tablets, with a firm fixed price ceiling value of $18,747.78 and a performance period through March 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to...
- This federal contract award, valued at $13,575.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4563654049 - BUPROPION HCL XL 300 MG TABLET 500S, with an ultimate completion date of February 14, 2024. The contract is a firm fixed-price award and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,133,134 units of Bupropion HCL XL 150 mg tablets. The contract has a ceiling value of $42,999.30 and a performance period through April 2, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 500 tablets of Bupropion HCL XL 150 mg. The contract has a total potential value of $2,209.29 and a completion date of February 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 and running through...
- This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Bupropion HCL XL 150 mg tablets. The contract has a ceiling value of $119,193.76 and a performance period through March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not have a set-aside designation. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded to...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FW0E4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Bupropion HCL XL 300 mg tablets (500 count) with a ceiling value of $13,236.86. The contract is a firm fixed price delivery order with an ultimate completion date of September 15, 2025, and was competitively awarded without set-aside restrictions. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.2k | 9/12/25 |